| 000 | 01834 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513211136.0 | ||
| 264 | 0 | _c20000518 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0003-990X | ||
| 024 | 7 |
_a10.1001/archpsyc.57.5.481 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBowden, C L | |
| 245 | 0 | 0 |
_aA randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. _h[electronic resource] |
| 260 |
_bArchives of general psychiatry _cMay 2000 |
||
| 300 |
_a481-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmbulatory Care |
| 650 | 0 | 4 |
_aAntimanic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLithium Carbonate _xadverse effects |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPsychiatric Status Rating Scales _xstatistics & numerical data |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aValproic Acid _xadverse effects |
| 700 | 1 | _aCalabrese, J R | |
| 700 | 1 | _aMcElroy, S L | |
| 700 | 1 | _aGyulai, L | |
| 700 | 1 | _aWassef, A | |
| 700 | 1 | _aPetty, F | |
| 700 | 1 | _aPope, H G | |
| 700 | 1 | _aChou, J C | |
| 700 | 1 | _aKeck, P E | |
| 700 | 1 | _aRhodes, L J | |
| 700 | 1 | _aSwann, A C | |
| 700 | 1 | _aHirschfeld, R M | |
| 700 | 1 | _aWozniak, P J | |
| 773 | 0 |
_tArchives of general psychiatry _gvol. 57 _gno. 5 _gp. 481-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archpsyc.57.5.481 _zAvailable from publisher's website |
| 999 |
_c10759358 _d10759358 |
||